Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Researchers From MIPT Study a Nanoscaffold for Heart Cells

March 1, 2018 By Moscow Institute of Physics and Technology

Biophysicists from MIPT have studied the structure of a nanofibrous scaffold, as well as its interaction with rat cardiac cells. The study, which is part of the research into heart tissue regeneration, revealed that cardiomyocytes—heart muscle cells—envelop nanofibers as they grow, while fibroblasts—connective tissue cells—tend to spread out on fibers forming several focal adhesion sites.

The study was conducted at MIPT’s Laboratory of Biophysics of Excitable Systems in collaboration with the researchers from the Shumakov Federal Research Center of Transplantology and Artificial Organs and the Institute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences. The article was published in the journal Acta Biomaterialia.

“Using three independent methods, we discovered that during their development on a nanofibrous scaffold, cardiomyocytes wrap the fibers on all sides creating a ‘sheath’ structure in the majority of cases,” explains Professor Konstantin Agladze, head of the Laboratory of Biophysics of Excitable Systems. “Fibroblasts, by contrast, have a more rigid structure and a much smaller area of interaction with the substrate, touching it only on one side.” Regenerative medicine seeks to repair or replace lost or damaged human cells, tissues, and organs. Tissue engineering is often the only way to restore the functions of the human heart and achieve recovery. Creating “patches” for a damaged heart demands more than merely understanding the properties of the corresponding tissue cells: One also needs to study their interaction with the substrate, as well as with the surrounding solution and the neighboring cells.

Getting the Right Scaffold is Half the Battle

Vital for the growth, development, and formation of regenerating tissues is the substrate on which cells are grown. The scaffolds used for cardiac tissue engineering are based on a matrix of polymer nanofibers. Nanofibers may vary in terms of elasticity and electrical conductivity, or they may have additional “smart” functions allowing them to release biologically active molecules at a certain stage. Nanofibers are designed to mimic the extracellular matrix, which surrounds the cells, providing structural support. In addition, nanofibers can be used as a medium for delivering substances into the surrounding cells in order to induce biochemical changes in them. So studying the interactions between the scaffold and heart cells is essential for choosing the right nanofiber features—i.e., those that would bring an artificial structure closer to that in a living organism.

Going Under the Microscope…

The team conducted a three-stage study to determine the structural features of cardiac cells as well as the nature of their interaction with the fibers.

First, the researchers studied the structure of cardiomyocytes and fibroblasts grown on a substrate of nanofibers using confocal laser scanning microscopy: The tiniest sections of the cell were illuminated and scanned point-by-point allowing for the reconstruction of 3D structures in the micrometric range. The structure of cardiomyocytes and fibroblasts (the nucleus and the components of the eukaryotic cytoskeleton) as well as that of the fiber was pre-stained with fluorescent antibodies. The obtained 3D images showed that both types of the studied cells were aligned along the fibers and had spindlelike shapes. However, this data was insufficient to study the cell-fiber interface.

Cell samples were then sectioned into ultrathin slices in a plane perpendicular to the direction of the fibers and “photographed” using transmission electron microscopy (TEM). In the course of the study, a beam of electrons was transmitted through the sections. A detector was placed behind the sections to detect those electrons that passed through. Their number does not merely depend on the thickness of the sample: It is also indicative of the properties of the material. Various cell structures absorb electrons that travel through the specimen differently. The researchers discovered that cardiomyocytes envelop nanofibers on all sides so that the fiber ends up being in the middle of the cell. Nevertheless, it remains separated from the cytoplasm by the cell membrane.

Fibroblasts do not “swallow” the fiber, they only touch it on one side. Moreover, TEM images demonstrate that the nucleus of the fibroblast is relatively rigid compared to other cell components. This makes fibroblasts less flexible, reducing their ability to stretch along the fiber. TEM made it possible to study the cross sections. Then, using scanning probe nanotomography, a comprehensive 3D model was created. The researchers took cells grown on a substrate of nanofibers and sliced them into 120-nanometer-thick sections. Their surface structure was studied with a silicon probe and reconstructed in 3D.

Cardiomyocytes Have Better Adhesion to the Substrate Than Fibroblasts

The researchers observed some important aspects of the cell-fiber interaction.

First of all, since stronger mechanical adhesion—i.e., cell-scaffold attachment—means cells are more stable growing on the substrate, cardiomyocytes will be firmly attached to the scaffold, while fibroblasts will be less stable.

Secondly, additional “smart” scaffold functions, such as the release of growth factors—protein molecules that stimulate cellular growth—will also differ depending on the cell type. In the case of cardiomyocytes, which tend to envelop the nanofiber, the released substances will diffuse directly from the fiber through the cell membrane and into the cytoplasm. In the case of fibroblasts, on the other hand, a certain amount of these substances will leak out.

Thirdly, cardiomyocytes isolate the polymer fibers from the surrounding solution. Since cardiomyocytes are responsible for the transfer of electromagnetic waves within the heart—and therefore for heart contractions—immersing the fibers of the scaffold completely in cardiomyocytes will enable researchers to test the electrical conductivity of the cells.

This study, as well as further investigation into the mechanisms of cell-substrate interactions, will enable the creation of nanofibers that would provide cells with the properties needed to form regenerative tissues.

Related Articles Read More >

A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
This is a Boston Scientific illustration of its Eluvia drug-eluting stent for treating peripheral artery disease or PAD.
How Boston Scientific is advancing its PAD-treating drug-eluting stent
An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]
The top nitinol cardiac medtech news of 2025 (so far)
Camgenium and Cardiac Tech partner on Pace-Protect safety device
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe